FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Heidrun Engler

Research Profile

Living Beings

Procedures

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Disorders

Urinary Bladder Neoplasms

Physiology

Cell Divisions

Concepts & Ideas

Drug Dose Response Relationship

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
TL Nagabhushan; Daniel Maneval; William F Benedict; Shu Fen Wen; P M Ihnat; Heidrun Engler; Robert J Connor
Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.
Todd Machemer; Heidrun Engler; Van Tsai; Seoju Lee; Susan Cannon-Carlson; Marcio Voloch; Thomas Schluep; Sundari Ravindran; Gary Vellekamp; Elena Brin; Douglas Cornell; Suganto Sutjipto; Shu Fen Wen; Mark Horn; Nico van Rooijen; Daniel Maneval; Beth Hutchins; Drake LaFace
Characterization of hemodynamic events following intravascular infusion of recombinant adenovirus reveals possible solutions for mitigating cardiovascular responses.
Robert J Connor; Jennifer M Anderson; Todd Machemer; Daniel Maneval; Heidrun Engler
Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Heidrun Engler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2007: TL Nagabhushan; Daniel Maneval; William F Benedict; Shu Fen Wen; P M Ihnat; Heidrun Engler; Robert J Connor
Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.
Cytokine & growth factor reviews 2007;18(5-6):389-94.
2005: Todd Machemer; Heidrun Engler; Van Tsai; Seoju Lee; Susan Cannon-Carlson; Marcio Voloch; Thomas Schluep; Sundari Ravindran; Gary Vellekamp; Elena Brin; Douglas Cornell; Suganto Sutjipto; Shu Fen Wen; Mark Horn; Nico van Rooijen; Daniel Maneval; Beth Hutchins; Drake LaFace
Characterization of hemodynamic events following intravascular infusion of recombinant adenovirus reveals possible solutions for mitigating cardiovascular responses.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(2):254-63.
2005: Robert J Connor; Jennifer M Anderson; Todd Machemer; Daniel Maneval; Heidrun Engler
Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens.
Urology 2005;66(1):224-9.
2004: Heidrun Engler; Todd Machemer; Jennifer Philopena; Shu Fen Wen; Erlinda Quijano; Murali Ramachandra; Van Tsai; Robert Ralston
Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-alpha.
Virology 2004;328(1):52-61.
2004: William F Benedict; Ziming Tao; Chang-Soo Kim; Xinqiao Zhang; Jain-Hua Zhou; Liana Adam; David J McConkey; Angela Papageorgiou; Mark F Munsell; Jennifer Philopena; Heidrun Engler; William Demers; Daniel Maneval; Colin P N Dinney; Robert J Connor
Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(3):525-32.
2004: Suzie H Pun; Nathalie C Bellocq; Aijie Liu; Greg Jensen; Todd Machemer; Erlinda Quijano; Thomas Schluep; Shufen Wen; Heidrun Engler; Jeremy D Heidel; Mark E Davis
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
Bioconjugate chemistry 2004;15(4):831-40.
2003: G William Demers; Duane E Johnson; Van Tsai; Shu Fen Wen; Erlinda Quijano; Todd Machemer; Jennifer Philopena; Murali Ramachandra; John A Howe; Paul Shabram; Robert Ralston; Heidrun Engler
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy.
Cancer research 2003;63(14):4003-8.
2003: Heidrun Engler; Todd Machemer; Thomas Schluep; Shu Fen Wen; Erlinda Quijano; Ken Wills; Alexis E Harper; Daniel Maneval; Susan E Conroy
Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(4):558-64.
2002: Motoyuki Yamashita; Charles J Rosser; Jain-Hua Zhou; Xin-Qiao Zhang; Robert J Connor; Heidrun Engler; Daniel Maneval; Takashi Karashima; Bogdan Czerniak; Colin P N Dinney; William F Benedict
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.
Cancer gene therapy 2002;9(8):687-91.
2002: Jürgen Kuball; Shu Fen Wen; Joachim Leissner; Derek Atkins; Patricia Meinhardt; Erlinda Quijano; Heidrun Engler; Beth Hutchins; Daniel Maneval; Michael J Grace; Mary Ann Fritz; Stephan Störkel; Joachim W Thüroff; Christoph Huber; Martin Schuler
Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):957-65.
2001: Murali Ramachandra; Amena Rahman; Aihua Zou; Mei Ting Vaillancourt; John A Howe; Douglas Antelman; Barry J Sugarman; G William Demers; Heidrun Engler; D Johnson; Paul Shabram
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy.
Nature biotechnology 2001;19(11):1035-41.
2001: C M Iqbal Ahmed; Duane E Johnson; G William Demers; Heidrun Engler; John A Howe; Ken Wills; Shu Fen Wen; Jeremy Shinoda; Josefina C Beltran; M Nodelman; Todd Machemer; Daniel Maneval; TL Nagabhushan; Barry J Sugarman
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers.
Cancer gene therapy 2001;8(10):788-95.
2001: Robert J Connor; Heidrun Engler; Todd Machemer; Jennifer Philopena; M T Horn; Suganto Sutjipto; Daniel Maneval; Stephen Youngster; T M Chan; James Bausch; J P McAuliffe; O Hindsgaul; TL Nagabhushan
Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium.
Gene therapy 2001;8(1):41-8.
1999: Heidrun Engler; S C Anderson; Todd Machemer; Jennifer Philopena; Robert J Connor; Shu Fen Wen; Daniel Maneval
Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents.
Urology 1999;53(5):1049-53.
1998: G William Demers; MP Harris; Shu Fen Wen; Heidrun Engler; Loretta L Nielsen; Daniel Maneval
A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth.
Cancer gene therapy 1998;5(4):207-14.
1998: S C Anderson; Duane E Johnson; MP Harris; Heidrun Engler; W Hancock; W M Huang; Ken Wills; RJ Gregory; Suganto Sutjipto; Shu Fen Wen; S Lofgren; H Michael Shepard; Daniel Maneval
p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(7):1649-59.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.